Pharma Marketing Advancement Led by Tech Expert
Anil Dobhal, a seasoned tech professional with 24 years of expertise, has joined Doceree as the Global Chief Technology Officer. His extensive experience in consumer marketing and data security is set to drive innovation in HCP programmatic marketing, transforming the pharmaceutical industry.
AI and ML: Pioneering Pharma Marketing Evolution
Doceree, a global platform for HCP programmatic marketing, is poised for groundbreaking changes. Hybrid strategies are taking center stage, and Dobhal’s arrival aligns perfectly with the company’s vision of using AI and ML to reshape pharma marketing. This will empower partners with actionable insights for exceptional business outcomes.
ESPYIANTM: Redefining Pharma Marketing
Doceree’s proprietary identity-resolution technology, ESPYIANTM, is making waves in the industry. Powered by AI, data integration, and analytics, ESPYIANTM precisely targets healthcare professionals (HCPs). With substantial Series A funding of $11 million, Doceree aims to establish itself as a global leader in programmatic pharma marketing solutions.
Driving Automated Excellence
Anil Dobhal envisions a future of automation and optimization in the programmatic ecosystem. Through AI, ML, and data science algorithms, he intends to enhance marketing initiatives for pharma and life sciences companies. This approach promises to secure better RPMs (ad revenue per thousand impressions) for publishers.
Expertise to Enrich Programmatic Offerings
Anil Dobhal’s proficiency in fraud systems and scalable data security adds a unique dimension to Doceree. His experience with major players like Times Internet Limited, Expedia, and GlobalLogic positions him to elevate Doceree’s programmatic offerings. By applying insights from the consumer space, Dobhal aims to address diverse market needs.
